Paper6542011
Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare.
Reddel RR and 1 other. Eur J Cancer Clin Oncol, 1984. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Papers, record 6542011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6542011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Cell Count | |
| Cell Division | |
| Cells, Cultured | |
| Dose-Response Relationship, Drug | |
| Estradiol | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Interphase | |
| Stimulation, Chemical | |
| Time Factors |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37324231 | Metabolic flare phenomenon mimicking disease progression on 18Flouride- Fluorodeoxyglucose PET/CT scan in breast cancer treated with paclitaxel-based chemotherapy. | Asia Ocean J Nucl Med Biol | 2023 | https://conductscience.org/library/papers/37324231 | PubMed |
| 36992561 | Mitocans induce lipid flip-flop and permeabilize the membrane to signal apoptosis. | Biophys J | 2023 | https://conductscience.org/library/papers/36992561 | PubMed |
| 33117280 | Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33117280 | PubMed |
| 32718075 | PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32718075 | PubMed |
| 32229068 | The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review. | Nucl Med Biol | 2021 | https://conductscience.org/library/papers/32229068 | PubMed |
| 24345432 | Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. | Breast Cancer Res | 2013 | https://conductscience.org/library/papers/24345432 | PubMed |
| 23134774 | A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen. | BMC Syst Biol | 2012 | https://conductscience.org/library/papers/23134774 | PubMed |
| 22419778 | Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. | Endocr Rev | 2012 | https://conductscience.org/library/papers/22419778 | PubMed |
| 20386540 | EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20386540 | PubMed |
| 18716795 | Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer. | J Cancer Res Clin Oncol | 2009 | https://conductscience.org/library/papers/18716795 | PubMed |
| 15750629 | Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. | Oncogene | 2005 | https://conductscience.org/library/papers/15750629 | PubMed |
| 10619490 | Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen. | Cell Prolif | 1999 | https://conductscience.org/library/papers/10619490 | PubMed |
| 8054267 | Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8054267 | PubMed |
| 8012034 | Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/8012034 | PubMed |
| 3606944 | Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3606944 | PubMed |
| 2661195 | Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. | Drugs | 1989 | https://conductscience.org/library/papers/2661195 | PubMed |
| 2605344 | Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells. | Breast Cancer Res Treat | 1989 | https://conductscience.org/library/papers/2605344 | PubMed |
| 1429832 | Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor. | J Cancer Res Clin Oncol | 1992 | https://conductscience.org/library/papers/1429832 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6542011
GET https://conductscience.org/api/papers/v1/6542011/authors